Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression (Q39108713)

9 September 2017

Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression (English)

1 reference

9 September 2017

0 references

1 reference

Kees Fluiter

4

0 references

Frank P Vleggaar

6

object named as

Frank P Vleggaar

1 reference

9 September 2017

2

Peter D Siersema

1 reference

9 September 2017

Romy E Verbeek

1

1 reference

9 September 2017

Fiebo J Ten Kate

3

1 reference

9 September 2017

Rhonda F Souza

5

1 reference

9 September 2017

Pauline Bus

7

1 reference

9 September 2017

Jantine W P M van Baal

8

1 reference

9 September 2017

17 August 2013

1 reference

Journal of Gastroenterology

9 September 2017

1 reference

9 September 2017

49

1 reference

9 September 2017

7

1 reference

9 September 2017

1121-1134

1 reference

How to make a Barrett esophagus: pathophysiology of columnar metaplasia of the esophagus

9 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Acid reflux and oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Incidence of adenocarcinoma among patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Esophageal adenocarcinoma incidence: are we reaching the peak?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Increasing incidence of Barrett's oesophagus in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Role of Toll-like receptors in gastrointestinal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Toll-like receptors, tissue injury, and tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

TLR signaling in the gut in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Pathogen recognition receptors, cancer and inflammation in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Broad expression of Toll-like receptors in the human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Negative regulation of toll-like receptor-mediated signaling by Tollip

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Toll-like receptors and their role in gastrointestinal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

A methylated phosphate group and four amide-linked acyl chains in leptospira interrogans lipid A. The membrane anchor of an unusual lipopolysaccharide that activates TLR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Endogenous ligands of TLR2 and TLR4: agonists or assistants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

The effect of proton pump inhibitors on the human microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Decreased Toll-interacting protein and peroxisome proliferator-activated receptor γ are associated with increased expression of Toll-like receptors in colon carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Helicobacter pylori induces increased expression of Toll-like receptors and decreased Toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Intracellular trafficking of interleukin-1 receptor I requires Tollip

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Tollip and Tom1 form a complex and recruit ubiquitin-conjugated proteins onto early endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Inflammatory gradient in Barrett's oesophagus: implications for disease complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Unlike esophageal squamous cells, Barrett's epithelial cells resist apoptosis by activating the nuclear factor-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

The immune cell composition in Barrett's metaplastic tissue resembles that in normal duodenal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

MSK1 and MSK2 inhibit lipopolysaccharide-induced prostaglandin production via an interleukin-10 feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Celecoxib for the prevention of sporadic colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0862-6

Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines.

21 January 2018

1 reference

12 December 2020

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

1 reference

12 December 2020

Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines

1 reference

12 December 2020

Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective.

1 reference

12 December 2020

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus

1 reference

12 December 2020

A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma.

1 reference

12 December 2020

Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.

1 reference

12 December 2020

Toll-like receptor 4 modulation as a strategy to treat sepsis

1 reference

12 December 2020

Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics

1 reference

12 December 2020

10.1007/S00535-013-0862-6

Identifiers

DOI

1 reference

9 September 2017

1 reference